KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Revenue (2016 - 2026)

Evolent Health has reported Revenue over the past 11 years, most recently at $468.7 million for Q4 2025.

  • For Q4 2025, Revenue fell 27.5% year-over-year to $468.7 million; the TTM value through Dec 2025 reached $1.9 billion, down 26.56%, while the annual FY2025 figure was $1.9 billion, 26.56% down from the prior year.
  • Revenue for Q4 2025 was $468.7 million at Evolent Health, down from $479.5 million in the prior quarter.
  • Over five years, Revenue peaked at $647.1 million in Q2 2024 and troughed at $215.1 million in Q1 2021.
  • A 5-year average of $432.7 million and a median of $456.5 million in 2025 define the central range for Revenue.
  • Biggest five-year swings in Revenue: surged 58.49% in 2022 and later tumbled 31.34% in 2025.
  • Year by year, Revenue stood at $248.4 million in 2021, then surged by 53.98% to $382.4 million in 2022, then soared by 45.4% to $556.1 million in 2023, then increased by 16.27% to $646.5 million in 2024, then decreased by 27.5% to $468.7 million in 2025.
  • Business Quant data shows Revenue for EVH at $468.7 million in Q4 2025, $479.5 million in Q3 2025, and $444.3 million in Q2 2025.